WebExhibit 10.3 . PARENT SUPPORT AGREEMENT . This PARENT SUPPORT AGREEMENT, dated as of October 15, 2024 (this “Agreement”), is entered into by and among FS Development Corp., a Delaware corporation (“Parent”), Gemini Therapeutics, Inc., a Delaware corporation (the “Company”), FS Development Holdings, LLC, a Delaware … WebGemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. The …
Our Team - Disc Medicine
WebJun 22, 2024 · About Gemini Therapeutics. Gemini Therapeutics is a clinical stage precision medicine company developing novel therapeutic compounds to treat genetically defined age-related macular degeneration ... WebDec 29, 2024 · Approximately $175 million of cash and cash equivalents to provide operating runway into 2025. WATERTOWN, Mass., Dec. 29, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (“Disc”), a clinical ... goodstuph thailand
Gemini Therapeutics Enrolls First Patient in Phase 1 Study ... - Eyewire+
WebFeb 28, 2024 · February 28, 2024 08:30 AM Eastern Standard Time. Remote-First-Company/Mass.-- ( BUSINESS WIRE )--Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing ... WebJan 10, 2024 · January 10, 2024 08:00 AM Eastern Standard Time. CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative ... WebFounded; 2015; Status; Acquired/ Merged; Employees; 5; Latest Deal Type; M&A; Gemini Therapeutics General Information. Description. Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic ... goodstuph agency